Pacira reported $293.59M in Debt for its fiscal quarter ending in September of 2026.





Debt Change Date
Astellas Pharma JPY 589.87B 23.92B Jun/2026
Bristol-Myers Squibb USD 42.88B 2.18B Sep/2026
Cara Therapeutics USD 0 0 Mar/2025
Coherus Biosciences USD 294.92M 1.25M Mar/2025
Heron Therapeutics USD 149.65M 157K Sep/2024
Ironwood Pharmaceuticals USD 583.99M 14.83M Dec/2024
J&J USD 49.04B 5.95B Jun/2026
Ligand Pharmaceuticals USD 1.13B 679.48M Jun/2026
Nektar Therapeutics USD 0 0 Jun/2022
Novo Nordisk DKK 118.72B 61.75B Mar/2025
Omeros USD 442.16M 199K Sep/2023
Pacira USD 293.59M 69.53M Sep/2026
Perrigo USD 3.29B 337.7M Jun/2026
Pfizer USD 62.67B 523M Sep/2026
Supernus Pharmaceuticals USD 40.17M 733K Jun/2026
Teva Pharmaceutical Industries USD 16.98B 110M Sep/2026
Xeris Pharmaceuticals USD 289.44M 30.89M Jun/2026
Zoetis USD 9.24B 0 Jun/2026